Find Federal Grants
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health · RFA-CA-19-028
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-019
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-020
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-021
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-022
Enhancing Linkage of STI and HIV Surveillance Data in the Ryan White HIV/AIDS Program (RWHAP)
Health Resources and Services Administration · HRSA-19-039
Centers for Disease Control and Prevention - ERA · RFA-DP-19-003
Centers for Disease Control and Prevention - ERA · RFA-GH-19-010
Centers for Disease Control and Prevention - ERA · RFA-GH-19-003
Innovations in Care Coordination for Children and Youth with Autism Spectrum Disorders and Other Developmental Disabilities Program
Health Resources and Services Administration · HRSA-19-061
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)
National Institutes of Health · RFA-AT-19-008
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)
National Institutes of Health · RFA-AT-19-009
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-19-009
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-19-031
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-19-030
Indian Health Service · HHS-2019-IHS-UIHP2-0001
Health Resources and Services Administration · HRSA-19-032
Health Resources and Services Administration · HRSA-19-052
Substance Abuse and Mental Health Services Adminis · TI-19-005
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
National Institutes of Health · PAR-19-142